Salem Investment Counselors’s Compass Therapeutics CMPX Stock Holding History

Salem Investment Counselors’s Portfolio CMPX Stock Details CMPX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-30,000	Closed	-$59.1K	–	1115
2023 Q3	$59.1K	Hold	30,000	–	–	﹤0.01%	497
2023 Q2	$95.1K	Hold	30,000	–	–	﹤0.01%	425
2023 Q1	$98.1K	Hold	30,000	–	–	﹤0.01%	419
2022 Q4	$151K	Hold	30,000	–	–	0.01%	362
2022 Q3	$68K	Hold	30,000	–	–	﹤0.01%	440
2022 Q2	$80K	Sell	30,000 -70,000	-70%	-$152K	﹤0.01%	434
2022 Q1	$137K	Hold	100,000	–	–	0.01%	381
2021 Q4	$317K	Buy	+100,000	New	+$332K	0.01%	320

Other funds holding CMPX

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

Salem Investment Counselors's CMPX Position: Q4 2023 in Review

Salem Investment Counselors sold out of Compass Therapeutics (CMPX) in Q4 2023, closing a stake of 30,000 shares — an estimated $59.1K sold.

Salem Investment Counselors first reported a position in CMPX in Q4 2021 and held it in 8 quarters. The position peaked at $317K in Q4 2021. 77 funds tracked by Wall St. Rank hold CMPX as of Q4 2023.

Salem Investment Counselors reported no remaining Compass Therapeutics position as of Q4 2023 after selling out during the quarter.
Salem Investment Counselors sold 30,000 Compass Therapeutics shares in Q4 2023, an estimated $59.1K.
Salem Investment Counselors first reported a position in Compass Therapeutics in Q4 2021 and held it in 8 quarters.
Salem Investment Counselors's Compass Therapeutics position peaked at $317K in Q4 2021.
77 funds tracked by Wall St. Rank held Compass Therapeutics as of Q4 2023.

Based on Salem Investment Counselors's 13F filing for Q4 2023, filed 16 Jan 2024.